Jonathan M. Harnoss

2.2k total citations · 1 hit paper
34 papers, 1.3k citations indexed

About

Jonathan M. Harnoss is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Jonathan M. Harnoss has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Jonathan M. Harnoss's work include Cancer, Hypoxia, and Metabolism (10 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Jonathan M. Harnoss is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Jonathan M. Harnoss collaborates with scholars based in Germany, United States and Ireland. Jonathan M. Harnoss's co-authors include Alexis Ulrich, Zora Modrušan, Hartmut Koeppen, Joerg D. Hoeck, Antonina V. Kurtova, Elaine E. Storm, Frédéric J. de Sauvage, Robert Piskol, Felipe de Sousa e Melo and Noelyn M. Kljavin and has published in prestigious journals such as Nature, Nature Communications and Nature Reviews Molecular Cell Biology.

In The Last Decade

Jonathan M. Harnoss

31 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer

2017 558 citations Felipe de Sousa e Melo, Antonina V. Kurtova et al. Nature profile →

Peers

Countries citing papers authored by Jonathan M. Harnoss

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Harnoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Harnoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Harnoss more than expected).

Fields of papers citing papers by Jonathan M. Harnoss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Harnoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Harnoss. The network helps show where Jonathan M. Harnoss may publish in the future.

Co-authorship network of co-authors of Jonathan M. Harnoss

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Harnoss. A scholar is included among the top collaborators of Jonathan M. Harnoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Harnoss. Jonathan M. Harnoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IRE1 is a promising therapeutic target in pancreatic cancer 2025 ·American Journal of Physiology-Cell Physiology ·(unknown), (unknown), C. Niemeyer, Julian C. Harnoss, Martin Schneider, Moritz J. Strowitzki, Jonathan M. Harnoss	3
2	A New Gold Standard? Impact of Broad-spectrum Penicillin-based Antibiotic Prophylaxis on Outcome After Pancreatoduodenectomy: Results of a Systematic Review and Meta-analysis (PROSPERO CRD42024559197) 2025 ·Annals of Surgery ·Julian C. Harnoss, (unknown), (unknown), Benedict Kinny‐Köster, Max Heckler, Rosa Klotz, Eva Kalkum, Jonathan M. Harnoss, Julian Musa, Pascal Probst, Christoph Michalski, Martin Loos, Thomas Hank	1
3	PERIoperative antibiotic prophylaxis in PANCreatic surgery (PeriPANC): protocol for a prospective observational study comparing antibiotic regimens and their impact on postoperative outcomes in pancreatic surgery 2025 ·BMJ Open ·(unknown), (unknown), Thomas Hank, (unknown), Benedict Kinny‐Köster, Max Heckler, Jonathan M. Harnoss, (unknown), Pascal Probst, Christoph Michalski, Martin Loos, Julian C. Harnoss	0
4	Temporal variation in nutritional status and preoperative anemia among patients with retroperitoneal soft tissue sarcoma: a retrospective longitudinal cohort study 2025 ·Langenbeck s Archives of Surgery ·(unknown), (unknown), Julian Musa, Jonathan M. Harnoss, Moritz J. Strowitzki, (unknown), (unknown), (unknown), Markus W. Büchler, Martin Schneider	0
5	Homeostasis control in health and disease by the unfolded protein response 2024 ·Nature Reviews Molecular Cell Biology ·Diego Acosta‐Alvear, Jonathan M. Harnoss, Peter Walter, Avi Ashkenazi	29
6	ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt Pathway 2024 ·Cancer Research Communications ·Jeffrey J. Rodvold, Matthew Grimmer, (unknown), Scot A. Marsters, (unknown), (unknown), (unknown), (unknown), Jonathan M. Harnoss, Whitney Shatz-Binder, Zora Modrušan, Thomas D. Wu, Jennie R. Lill, Elisia Villemure, Joachim Rudolph, Felipe de Sousa e Melo, Avi Ashkenazi	7
7	Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation 2022 ·The Journal of Cell Biology ·Ofer Guttman, Adrien Le Thomas, Scot A. Marsters, David A. Lawrence, (unknown), Iratxe Zuazo-Gaztelu, Jonathan M. Harnoss, Simone M. Haag, Aditya Murthy, Geraldine Strasser, Zora Modrušan, Thomas D. Wu, Ira Mellman, Avi Ashkenazi	28
8	The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer 2022 ·JCI Insight ·Kilian B. Kennel, (unknown), Praveen Radhakrishnan, Nathalia A. Giese, Thomas Giese, (unknown), (unknown), Moritz J. Strowitzki, Cormac T. Taylor, Ben Wielockx, Martin Schneider, Jonathan M. Harnoss	7
9	Decoding non-canonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α 2021 ·Nature Communications ·Adrien Le Thomas, Elena Ferri, Scot A. Marsters, Jonathan M. Harnoss, David A. Lawrence, Iratxe Zuazo-Gaztelu, Zora Modrušan, Sara M. Chan, Margaret Solon, Cécile Chalouni, Weihan Li, Hartmut Koeppen, Joachim Rudolph, Weiru Wang, Thomas D. Wu, Peter Walter, Avi Ashkenazi	41
10	Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses 2021 ·JCI Insight ·Moritz J. Strowitzki, (unknown), (unknown), (unknown), Praveen Radhakrishnan, (unknown), (unknown), (unknown), (unknown), (unknown), Jonathan M. Harnoss, Johannes Klose, Thomas Schmidt, Alfonso Blanco, Cormac T. Taylor, Martin Schneider	14
11	High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases 2019 ·British Journal of Cancer ·Moritz J. Strowitzki, Praveen Radhakrishnan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Florian W. R. Vondran, Jonathan M. Harnoss, Johannes Klose, Thomas Schmidt, Martin Schneider	14
12	Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells 2018 ·American Journal Of Pathology ·Moritz J. Strowitzki, Johanna Kirchberg, (unknown), (unknown), (unknown), (unknown), Jonathan M. Harnoss, Felix Lasitschka, Thomas Schmidt, Praveen Radhakrishnan, Alexis Ulrich, Martin Schneider	16
13	Coordination between Two Branches of the Unfolded Protein Response Determines Apoptotic Cell Fate 2018 ·Molecular Cell ·Tsun-Kai Chang, David A. Lawrence, Min Lu, Jenille Tan, Jonathan M. Harnoss, Scot A. Marsters, Peter Liu, Wendy Sandoval, Scott E. Martin, Avi Ashkenazi	130
14	A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer breakdown → 2017 ·Nature ·Felipe de Sousa e Melo, Antonina V. Kurtova, Jonathan M. Harnoss, Noelyn M. Kljavin, Joerg D. Hoeck, Jeffrey Hung, (unknown), Elaine E. Storm, Zora Modrušan, Hartmut Koeppen, Gerrit J.P. Dijkgraaf, Robert Piskol, Frédéric J. de Sauvage	558
15	Porcine arteriogenesis based on vasa vasorum in a novel semi-acute occlusion model using high-resolution imaging 2017 ·Heart and Vessels ·Jonathan M. Harnoss, Florian Krackhardt, (unknown), (unknown), Dieter Felsenberg, Konrad Neumann, Lilach O. Lerman, Fabian Riediger, Philipp Hillmeister, Peter Bramlage, Ivo Buschmann	5
16	Insights into coronary collateral formation from a novel porcine semiacute infarction model 2017 ·Coronary Artery Disease ·Florian Krackhardt, Jonathan M. Harnoss, Matthias Waliszewski, (unknown), (unknown), Dieter Felsenberg, Konrad Neumann, (unknown), Philipp Hillmeister, Rolf Gebker, Ingo Paetsch, Fabian Riediger, Peter Bramlage, Ivo Buschmann	3
17	Antibiotics Versus Surgical Therapy for Uncomplicated Appendicitis 2016 ·Annals of Surgery ·Julian C. Harnoss, (unknown), Pascal Probst, Kathrin Grummich, (unknown), Jonathan M. Harnoss, Alexis Ulrich, Markus W. Büchler, Markus K. Diener	126
18	Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis 2015 ·Annals of Surgical Oncology ·Christine Leowardi, (unknown), Ulf Hinz, Jonathan M. Harnoss, Ignazio Tarantino, Felix Lasitschka, Alexis Ulrich, Markus W. Büchler, Martina Kadmon	28
19	Use and results of consensus definitions in pancreatic surgery: A systematic review 2013 ·Surgery ·Julian C. Harnoss, Alexis Ulrich, Jonathan M. Harnoss, Markus K. Diener, Markus W. Büchler, Thilo Welsch	112
20	Qualität und Qualitätssicherung der Lehre in der Chirurgie – Empfehlungen aus einem Workshop der Chirurgischen Arbeitsgemeinschaft für Qualitätssicherung 2010 ·Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie ·(unknown), (unknown), (unknown), Jonathan M. Harnoss, (unknown), Sven Flemming, U. Obertacke, CD Heidecke, A. Busemann	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact